HB 2385 Summary

• Adds 19 new synthetic cathinone compounds to Schedule I controlled substances, including mephedrone, methylone, ethylone, and various substituted cathinones with specific structural modifications.

• Adds 15 new synthetic cannabinoid compounds to Schedule I controlled substances, including APINACA, PB-22, AB-FUBINACA, ADB-PINACA, and related analogs with various structural variants.

• Moves nabilone from Schedule II to Schedule IV hallucinogenic substances.

• Adds dronabinol (oral solution of delta-9-tetrahydrocannabinol approved by FDA) to Schedule IV hallucinogenic substances.

• Updates Hawaii's Uniform Controlled Substances Act to align with federal Controlled Substances Act amendments as required by Hawaii Revised Statutes section 329-11.